Sotatercept for the Treatment of Pulmonary Arterial Hypertension
医学
肺动脉高压
心脏病学
内科学
作者
Marc Humbert,Vallerie V. McLaughlin,J. Simon R. Gibbs,Mardi Gomberg‐Maitland,Marius M. Hoeper,Ioana R. Preston,Rogério Souza,Aaron B. Waxman,Pilar Escribano Subías,Jeremy Feldman,G. Meyer,David Montani,Karen M. Olsson,Solaiappan Manimaran,Jennifer Barnes,Peter G. Linde,Janethe de Oliveira Pena,David B. Badesch
Treatment with sotatercept resulted in a reduction in pulmonary vascular resistance in patients receiving background therapy for pulmonary arterial hypertension. (Funded by Acceleron Pharma; PULSAR ClinicalTrials.gov number, NCT03496207.).